Literature DB >> 26241188

Therapy: New fusion protein reduces IL-1-mediated inflammation.

João H Duarte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26241188     DOI： 10.1038/nrrheum.2015.108

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra.

Authors:  Leo A B Joosten; Tania O Crişan; Tania Azam; Maartje C P Cleophas; Marije I Koenders; Frank L van de Veerdonk; Mihai G Netea; Soohyun Kim; Charles A Dinarello
Journal:  Ann Rheum Dis       Date:  2015-07-14       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.